Antidiabetic burdens among geriatric diabetic patients and its association with quality of life
Geriatric diabetic patients contribute to the major demographic background of diabetic patients follow up in primary health clinics. Despite their increasing age and morbidities, they are still targeted towards good sugar control achieving ideal HbA1c level, without taking into consideration of t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kulliyyah of Allied Health Sciences
2019
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/77675/ http://irep.iium.edu.my/77675/ http://irep.iium.edu.my/77675/1/ANTIDIABETIC%20BURDENS%20AMONG%20GERIATRIC%20DIABETIC%20PATIENTS%20AND%20ITS%20ASSOCIATION%20WITH%20QUALITY%20OF%20LIFE%20_%20INTERNATIONAL%20JOURNAL%20OF%20ALLIED%20HEALTH%20SCIENCES.pdf |
| Summary: | Geriatric diabetic patients contribute to the major demographic background of
diabetic patients follow up in primary health clinics. Despite their increasing age and
morbidities, they are still targeted towards good sugar control achieving ideal HbA1c
level, without taking into consideration of their quality of life. This study aims to
determine the prevalence of antidiabetic usage among geriatric diabetic patients and
their association with the patients quality of life. A cross-sectional study was done
among 269 geriatric diabetic patients in all government health clinics in Kuantan using
Diabetes Quality of Life questionnaire. SPSS version 23 is used for statistical analysis.
Most of the geriatrics are female (61%), Malay (84.8%), pensioner (54.3%), education
up to primary school (52%) and stay with family members (93.7%). In terms of
antidiabetic agents, mostly depend on two antidiabetic agents (48%) followed by
single antidiabetic agent (32%). 0.4% still taking glibenclamide despite its risk of
hypoglycaemia. Usage of insulin is still common in the elderly in which 21% of them
are on intermediate-acting insulin, 15.6% on premixed insulin and 7.8% on shortacting insulin. Interestingly, those taking a higher number of antidiabetic agents are
associated with higher DQOL score (p = 0.03) compared to those taking one or two
antidiabetic medications. Those taking long-acting insulin also significantly have
higher DQOL score (0.037). Despite the risk of polypharmacy, geriatric patients do
benefit the better quality of life with the further intensification of their antidiabetic
medications according to guidelines. Usage of long-acting |
|---|